Attorney Advertising– NEW YORK– A class-action lawsuit recently filed accuses the makers of the popular heartburn medication Zantac of intentionally concealing risks. For more information, visit: www.bgandg.com/zantac.
The suit maintains that Zantac has been found to contain a carcinogenic chemical at 26,000 times the limit approved by the U.S. Food & Drug Administration. In response, the team at Bronstein Gewirtz And Grossman is working tirelessly to alert consumers and to help consumers find out their rights.
If you or a loved one have taken Zantac at any time between January 1, 2010 and the present, then you may be eligible for compensation. Know your rights! Reach out to Bronstein Gewirtz and Grossman LLC today. For more information, visit: www.bgandg.com/zantac.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
212-697-6484 | [email protected]